Wells Fargo raised the firm’s price target on HCA Healthcare to $303 from $291 and keeps an Equal Weight rating on the shares. HCA’s strong 2024 guidance was well-received despite core Q4 results that may not have exceeded a fairly high bar going into the quarter, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HCA:
- HCA Healthcare price target raised to $345 from $320 at Truist
- HCA Healthcare price target raised to $322 from $308 at RBC Capital
- HCA Healthcare price target raised to $330 from $280 at Deutsche Bank
- HCA Healthcare price target raised to $354 from $338 at Leerink
- HCA Healthcare price target raised to $330 from $315 at Oppenheimer
